Phase separation of p53 precedes aggregation and is affected by oncogenic mutations and ligandsElaine C. Petronilho, Jerson L. Silva, Guilherme A. P. de Oliveira et al.|Chemical Science|2021Cited by 108
Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid OligomersMurilo M. Pedrote, Guilherme A. P. de Oliveira, Enrico Gratton et al.|iScience|2020Cited by 82
Loss of the p53 transactivation domain results in high amyloid aggregation of the Δ40p53 isoform in endometrial carcinoma cellsNataly Melo dos Santos, Etel Rodrigues Pereira Gimba, Jerson L. Silva et al.|Journal of Biological Chemistry|2019Cited by 50